Daptomycin as a promising antimicrobial agent for the treatment of serious infections caused by resistant gram-positive organisms

Dear Editor, Multidrug-resistant (MDR) Gram-positive bacteria have posed a major therapeutic challenge in the past few years.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Indian journal of medical microbiology 2014-07, Vol.32 (3), p.353-354
Hauptverfasser:	Tarai, B, Das, P, Kumar, D
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Infective Agents - pharmacology Anti-Infective Agents - therapeutic use Antimicrobial agents Bacteriology Daptomycin - pharmacology Daptomycin - therapeutic use Drug Resistance, Bacterial Gram-Positive Bacteria - drug effects Gram-Positive Bacteria - isolation & purification Gram-Positive Bacterial Infections - drug therapy Gram-Positive Bacterial Infections - microbiology Humans Microbial Sensitivity Tests Organisms Staphylococcus infections
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Dear Editor, Multidrug-resistant (MDR) Gram-positive bacteria have posed a major therapeutic challenge in the past few years.
ISSN:	0255-0857 1998-3646
DOI:	10.4103/0255-0857.136616